相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides
Ting Zhang et al.
BIOMATERIALS (2015)
Characterization of the gila monster (Heloderma suspectum suspectum) venom proteome
Kristian W. Sanggaard et al.
JOURNAL OF PROTEOMICS (2015)
DIABETES A smart insulin patch
Omid Veiseh et al.
NATURE (2015)
Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification
Feng Qi et al.
ACTA BIOMATERIALIA (2014)
Fluorescent Exendin-4 Derivatives for Pancreatic β-Cell Analysis
Susan M. Clardy et al.
BIOCONJUGATE CHEMISTRY (2014)
In situ gelling polyvalerolactone-based thermosensitive hydrogel for sustained drug delivery
Gyan P. Mishra et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
A Novel Doxorubicin-Loaded in Situ Forming Gel Based High Concentration of Phospholipid for Intratumoral Drug Delivery
Wenqi Wu et al.
MOLECULAR PHARMACEUTICS (2014)
Global diets link environmental sustainability and human health
David Tilman et al.
NATURE (2014)
Multilayer nanoparticles for sustained delivery of exenatide to treat type 2 diabetes mellitus
Jae Yeon Kim et al.
BIOMATERIALS (2013)
A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel
Kun Li et al.
BIOMATERIALS (2013)
Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability
Feng Qi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Injectable implants for the sustained release of protein and peptide drugs
Priyanka Agarwal et al.
DRUG DISCOVERY TODAY (2013)
Effect of water on exenatide acylation in poly(lactide-co-glycolide) microspheres
Rongcai Liang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Once-Weekly Exenatide: An Extended-Duration Glucagon-Like Peptide Agonist for the Treatment of Type 2 Diabetes Mellitus
Molly G. Minze et al.
PHARMACOTHERAPY (2013)
Pharmacokinetic/pharmacodynamic studies on exenatide in diabetic rats
Xin-gang Li et al.
ACTA PHARMACOLOGICA SINICA (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
In situ forming implants - an attractive formulation principle for parenteral depot formulations
Sabine Kempe et al.
JOURNAL OF CONTROLLED RELEASE (2012)
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Juris J. Meier
NATURE REVIEWS ENDOCRINOLOGY (2012)
The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent
Brian L. Furman
TOXICON (2012)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Recent advances and challenges in designing stimuli-responsive polymers
Fang Liu et al.
PROGRESS IN POLYMER SCIENCE (2010)
Goals of Treatment for Type 2 Diabetes β-Cell preservation for glycemic control
Piero Marchetti et al.
DIABETES CARE (2009)
Pharmacokinetics and Efficacy of a Biweekly Dosage Formulation of Exenatide in Zucker Diabetic Fatty (ZDF) Rats
Hyun-Hee Kwak et al.
PHARMACEUTICAL RESEARCH (2009)
Correlation of in vivo and in vitro release data for rh-INFα lipid implants
M. Schwab et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Estimating the long-term cost-effectiveness of exenatide in the United States: An adjunctive treatment for type 2 diabetes mellitus
Michael E. Minshall et al.
VALUE IN HEALTH (2008)
Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels
Mizuna Kimura et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2007)
In situ forming parenteral drug delivery systems: an overview
CB Packhaeuser et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats
P Chaturvedi et al.
PHYTOTHERAPY RESEARCH (2004)
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
Q Wang et al.
DIABETOLOGIA (2002)
A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat
MJ Reed et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)